NASDAQ : ARAY
Accuray Incorporated — Key statistics
Healthcare · Medical Devices · United States
Last price 0.14 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 16.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 16.74M |
| Enterprise Value | 159.99M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 119.56M |
| Shares Outstanding | 119.56M |
| Shares Change (YoY) | +19.33% |
| Shares Change (QoQ) | +1.68% |
| Owned by Insiders (%) | 4.58% |
| Owned by Institutions (%) | 43.44% |
| Float | 113.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| Forward PS | 0.04 |
| PB Ratio | 0.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.50 |
| Quick Ratio | 0.66 |
| Debt / Equity | 4.41 |
| Debt / EBITDA | 31.71 |
| Debt / FCF | n/a |
| Interest Coverage | -0.31 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -80.08% |
| Return on Assets (ROA) | -1.40% |
| Return on Invested Capital (ROIC) | -5.54% |
| Return on Capital Employed (ROCE) | -4.07% |
| Weighted Average Cost of Capital (WACC) | 13.96% |
| Revenue Per Employee | $496,844 |
| Profits Per Employee | -$60,808 |
| Employee Count | 809 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 2.02 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.95M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -90.28% |
| 50-Day Moving Average | 0.22 |
| 200-Day Moving Average | 0.37 |
| Relative Strength Index (RSI) | 33.21 |
| Average Volume (20 Days) | 1,991,429 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.05M |
| Short Previous Month | 7.39M |
| Short % of Shares Out | 4.22% |
| Short % of Float | 4.44% |
| Short Ratio (days to cover) | 0.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 401.95M |
| Gross Profit | 111.45M |
| Operating Income | -10.27M |
| Pretax Income | -47.25M |
| Net Income | -49.19M |
| EBITDA | -3.53M |
| EBIT | -10.27M |
| Loss Per Share | -$0.40 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 40.62M |
| Total Debt | 183.87M |
| Net Cash | -143.25M |
| Net Cash Per Share | -$1.20 |
| Equity (Book Value) | 41.70M |
| Book Value Per Share | 0.35 |
| Working Capital | 96.37M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -6.98M |
| Capital Expenditures | -5.86M |
| Depreciation & Amortization | 6.74M |
| Net Borrowing | 3.65M |
| Free Cash Flow | -12.84M |
| FCF Per Share | -$0.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 27.73% |
| Operating Margin | -2.56% |
| Pretax Margin | -11.75% |
| Profit Margin | -12.24% |
| EBITDA Margin | -0.88% |
| EBIT Margin | -2.56% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -19.33% |
| Shareholder Yield | -19.33% |
| Earnings Yield | -286.53% |
| FCF Yield | -76.72% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |